18 Jun 20
News
18 Jun 20
Biocomposites announces STIMULAN® products added to NHS Supply Chain
STIMULAN is the first calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft tissue
Keele, UK,  18 June 2020 – Biocomposites, an international medical devices company that engineers, manufactures and…...
23 Apr 20
News
23 Apr 20
Biocomposites announces new CE Mark for STIMULAN®
First calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft tissue
Keele, UK, 23 April 2020 – Biocomposites, an international medical devices company that engineers, manufactures and…...
15 Apr 20
News
15 Apr 20
Biocomposites Appoints President, Biocomposites Inc.
Targeting reconstruction, spine, trauma and foot and ankle
Keele, UK, 15 April 2020 – Biocomposites, an international medical device company that engineers, manufactures and…...
4 Mar 20
News
4 Mar 20
Biocomposites announces U.S. launch of new STIMULAN® Rapid Cure 3cc product
Targeting smaller voids in foot and ankle, orthopaedic reconstruction and trauma
Keele, UK, 4 March 2020 – Biocomposites, an international medical device company that engineers, manufactures and…...
20 Mar 20
News
20 Mar 20
Biocomposites Status on Novel Coronavirus (COVID-19)
The recent events and rise of the COVID-19 virus on a global scale have brought challenges…...
Pioneering calcium compounds

Innovation is at the very heart of what we do, resulting in over 100 grants and registrations.

Musculoskeletal infection

Growth of antibiotic-resistant biofilms continues to outpace the development of new antibiotics.

Singular focus

Deep expertise and singular focus on calcium compound medical devices

Dedicated to quality

Manufacturing, processing, testing and distribution are all handled in-house

Your specialty

Access case studies, clinical and pre-clinical papers for musculoskeletal infection, trauma and spine to see how we are innovating across a wide range of clinical applications to help surgeons and their patients.

Musculoskeletal infections

Musculoskeletal infections, including infected non-unions, osteomyelitis and periprosthetic joint infections, are one of the biggest healthcare challenges of the 21st century.

As the rapid growth of antibiotic-resistant strains and biofilms continues to outpace the development of new antibiotics and antibiotic strategies, care delivery is becoming increasingly challenging and complicated.

Trauma

Bone and joint trauma, such as fractures and dislocations, are common and vary in severity from single fractures to multiple, life-threatening musculoskeletal injuries.

The most clinically challenging of these for the surgeon, and those that have the most socioeconomic burden, are open fractures. These often involve damage to the surrounding soft tissue, resulting in complications such as tissue and deep bone infection or long-term non-union.

Why Biocomposites?

At Biocomposites, we are pioneering calcium compound devices to regenerate and repair bone and soft tissue. With over 30 years’ experience of manipulating the surface chemistry and crystalline properties of calcium compounds, we engineer and manufacture products at the forefront of calcium technology.

  • Singular focus
  • Proprietary technology
  • Dedicated to quality
Learn more